24/7 Market News: LIXTE Holds the World's Only Clinical-Stage PP2A InhibitorUnlocking a New Era in Cancer TreatmentSeptember 05, 2025 8:35 AM EDT | Source: 24/7 Market NewsDenver, Colorado--(Newsfile Corp. - September 5, 2025) - 247marketnews.com, a pioneer in digital media dedicated to the swift distribution of financial market news and corporate information, underscores the scientific significance of LIXTE Biotechnology Holdings, Inc. (NASDAQ: LIXT), a clinical-stage biotechnology company de ...